
Click
here
to
take
the
2014
survey!
It will take only 10 minutes of your
time. In exchange, you will receive complete survey results plus insights from our qualitative research. Plus, you could win an Apple iPad!
Marc Duey, CEO of ProMetrics will be presenting results at the CBI Speed to Therapy Conference in Philadelphia
Welcome to ProMetrics' 2nd Annual
Speed-To-Therapy Survey
Speed-To-Therapy, Time-To-Fill, Turnaround Time, Time-To-Ship are used interchangeably and mean different things for different stakeholders.
It is important to measure speed-to-therapy for specialty drugs to evaluate how much time it takes manufacturers, physicians, insurance companies, hubs, and specialty pharmacies to get essential medications to patients.
Our survey is designed to understand the differences in Speed-To-Therapy better.
Last year, more than 100 people participated in the survey. BioPharma and Specialty Pharmacy represented about 80% of the participants.
Only 40% of survey participants agree that the product they chose was behind industry standard
-BUT-
More than 70% of participants agree that significant improvements need to be made in Speed-To-Therapy performance.
This year, the survey digs into the deeper layers of why speed-to-therapy differs among brands and among channel partners supporting a brand.
The survey will provide insights into:
-
Median speed-to-therapy for a specialty brands
-
How do oral oncology drugs compare to other drugs
-
Influence of Hub services on speed-to-therapy
-
Interventions that results in a faster speed-to-therapy
-
Specialty Pharmacy best practices
We encourage anyone who has first had or second hand experience in monitoring or influencing Speed-To-Therapy to participate.
Click here to take our 2014 Survey
It will take only 10 minutes of your time. In exchange, you will receive complete survey results plus insights from our qualitative research. Plus, you could win an Apple iPad!
2014 Speed-To-Therapy Survey
2013 Speed-To-Therapy Benchmarking Survey